Cargando…
Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display
To identify new antibodies for the treatment of plasma cell disorders including multiple myeloma (MM), a single-chain Fragment variable (scFv) antibody library was generated by immunizing mice with patient-derived malignant plasma cells. To enrich antibodies binding myeloma antigens, phage display w...
Autores principales: | Krohn, Steffen, Boje, Ammelie Svea, Gehlert, Carina Lynn, Lutz, Sebastian, Darzentas, Nikos, Knecht, Henrik, Herrmann, Dietrich, Brüggemann, Monika, Scheidig, Axel J., Weisel, Katja, Gramatzki, Martin, Peipp, Matthias, Klausz, Katja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248769/ https://www.ncbi.nlm.nih.gov/pubmed/35784366 http://dx.doi.org/10.3389/fimmu.2022.908093 |
Ejemplares similares
-
Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody
por: Gehlert, Carina Lynn, et al.
Publicado: (2022) -
NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats
por: Lipinski, Britta, et al.
Publicado: (2023) -
A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries
por: Klausz, Katja, et al.
Publicado: (2017) -
Generation and engineering of potent single domain antibody-based bispecific IL-18 mimetics resistant to IL-18BP decoy receptor inhibition
por: Lipinski, Britta, et al.
Publicado: (2023) -
Fc-engineering significantly improves the recruitment of immune effector cells by anti-ICAM-1 antibody MSH-TP15 for myeloma therapy
por: Klausz, Katja, et al.
Publicado: (2020)